Home / Services / Health economics
FOR AGENCIES · RESEARCHERS · HEALTH ORGANIZATIONS
Economic evidence on what health programs and interventions cost, what they achieve, and whether they are worth it — led by PhD-level health economists from our network.
Incremental cost-effectiveness, cost per outcome and cost per QALY or DALY, with transparent assumptions.
Monetized costs and benefits of programs for funders and oversight bodies.
Program and intervention costing, including micro-costing and activity-based approaches.
What adopting a program or technology means for a payer or agency budget over time.
Decision trees, Markov and simulation models to compare scenarios and interventions.
One-way, scenario and probabilistic analyzes that show how robust the conclusions are.
Economic components of program evaluations and funding requests.
Cost-effectiveness aims and economic sections for research proposals.
Business cases for programs, technologies and AI tools.
A short conversation to understand your question, data and deadline.
A written analysis or evaluation plan with methods, deliverables and timeline.
Analysis by senior specialists, with reproducible code and clear documentation.
Help interpreting results, responding to reviewers and preparing outputs.
Yes. Our cost-effectiveness and modeling work applies to domestic and global health interventions.
Yes. We can design the economic component alongside an outcome evaluation, or work with data already collected.
We follow recognized good-practice guidance for economic evaluation and reporting, adapted to the funder or agency.
Work with SmartDaaS
SmartDaaS is a principal-led firm. Every engagement is directed by the principal and staffed with the senior specialists it needs from our network of biostatisticians, epidemiologists, health economists, data scientists and clinicians.
Start a conversation